LEADER 05479nam 22006375 450 001 9910367257903321 005 20200701050842.0 010 $a981-329-366-7 024 7 $a10.1007/978-981-32-9366-3 035 $a(CKB)4100000009938170 035 $a(MiAaPQ)EBC5984000 035 $a(DE-He213)978-981-32-9366-3 035 $a(PPN)260304255 035 $a(EXLCZ)994100000009938170 100 $a20191123d2020 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aOxidative Stress in Lung Diseases$b[electronic resource] $eVolume 2 /$fedited by Sajal Chakraborti, Narasimham L. Parinandi, Rita Ghosh, Nirmal K. Ganguly, Tapati Chakraborti 205 $a1st ed. 2020. 210 1$aSingapore :$cSpringer Singapore :$cImprint: Springer,$d2020. 215 $a1 online resource (xvi, 488 pages) $cillustrations 311 $a981-329-365-9 327 $aPart A -- Chapter 1. The effects of oxidative stress on the pulmonary surfactant and the role of lipids in this scenario -- Chapter 2. Oxidative stress in experimental models of acute lung injury -- Chapter 3. Potential of mesenchymal stem cells in modulating oxidative stress in the management of lung diseases -- Chapter 4. Role of NADPH oxidase induced oxidative stress in matrix metalloprotease-mediated lung diseases -- Chapter 5. Oxidative stress mechanisms in the pathogenesis of environmental lung diseases -- Part B -- Chapter 6. Oxidative stress induced mitochondrial dysfunction and asthma -- Chapter 7. Regulation of antioxidant Nrf2 signaling, an important pathway in COPD -- Chapter 8. Role of smoke-induced oxidative stress in pathogenesis of chronic obstructive pulmonary disease -- Chapter 9. Oxidative stress in obstructive and restrictive lung diseases -- Chapter 10. The use of ozone as redox modulator in the treatment of the chronic obstructive pulmonary disease -- Chapter 11. TRP channels, oxidative stress and chronic obstructive pulmonary disease -- Chapter 12. Paraquat induced oxidative stress and lung inflammation -- Chapter 13. Environmental, occupational and cancer drug induced oxidative stress in lung fibrosis -- Part C -- Chapter 14. Respiratory syncytial virus-induced oxidative stress in lung pathogenesis -- Chapter 15. Reactive oxygen species: Friends or foes of lung cancer? -- Chapter 16. Roles of long non-coding RNAs in lung cancer -- Chapter 17. modulator of therapeutic response in non small cell lung carcinoma -- Chapter 18. old story, new modalities!.Part D -- Chapter 19. Oxidative stress and therapeutic development in lung cancer -- Chapter 20. Regulation of oxidative stress by nitric oxide defines lung development and Diseases -- Chapter 21. Epidermal growth factor receptor: promising targets for non-small cell lung cancer -- Chapter 22. Oxygenated lipid products in COPD and asthma: a clinical picture. . 330 $aThis is the second volume of the comprehensive, two-volume work on oxidative stress in lung diseases. Adopting a multidisciplinary approach, it demonstrates the cellular and molecular mechanisms associated with ROS (reactive oxygen species)-induced initiation and progression of a variety of lung diseases, such as COPD, emphysema, asthma, cystic fibrosis, occupational pulmonary diseases and pulmonary hypertension and discusses points for therapeutic intervention. The book also covers translational research and the latest research on prevention and therapeutics. Each chapter includes in-depth insights into the mechanisms associated with lung diseases and into identifying targets for drug development. Bridging the gap between fundamental and translational research, and examining applications in the biomedical and pharmaceutical industry, it is a thought- provoking read for basic and applied scientists engaged in biomedical research. 606 $aOxidative stress 606 $aRespiratory organs?Diseases 606 $aMedical biochemistry 606 $aBiomedical engineering 606 $aOxidative Stress$3https://scigraph.springernature.com/ontologies/product-market-codes/L16070 606 $aPneumology/Respiratory System$3https://scigraph.springernature.com/ontologies/product-market-codes/H33134 606 $aMedical Biochemistry$3https://scigraph.springernature.com/ontologies/product-market-codes/H35005 606 $aBiomedical Engineering/Biotechnology$3https://scigraph.springernature.com/ontologies/product-market-codes/B24000 615 0$aOxidative stress. 615 0$aRespiratory organs?Diseases. 615 0$aMedical biochemistry. 615 0$aBiomedical engineering. 615 14$aOxidative Stress. 615 24$aPneumology/Respiratory System. 615 24$aMedical Biochemistry. 615 24$aBiomedical Engineering/Biotechnology. 676 $a616.24 702 $aChakraborti$b Sajal$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aParinandi$b Narasimham L$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aGhosh$b Rita$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aGanguly$b Nirmal K$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aChakraborti$b Tapati$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910367257903321 996 $aOxidative Stress in Lung Diseases$92022554 997 $aUNINA